4//SEC Filing
Reid James 4
Accession 0001726978-20-000392
CIK 0001726978other
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 4:12 PM ET
Size
12.6 KB
Accession
0001726978-20-000392
Insider Transaction Report
Form 4
Reid James
Director
Transactions
- Exercise/Conversion
Class A Common Stock
2020-11-19$10.00/sh+2,500$25,000→ 2,500 total - Sale
Class A Common Stock
2020-11-19$126.71/sh−287$36,366→ 1,408 total - Exercise/Conversion
Director Stock Options (right to buy)
2020-11-19−2,500→ 61,622 totalExercise: $10.00Exp: 2028-04-26→ Class A Stock (2,500 underlying) - Sale
Class A Common Stock
2020-11-19$127.62/sh−1,408$179,689→ 0 total - Sale
Class A Common Stock
2020-11-19$125.81/sh−805$101,277→ 1,695 total
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.50 to $126.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.52 to $127.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.53 to $127.62, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F4]The shares subject to the option shall vest and become exercisable, subject to continued service, in 12 equal quarterly installments over the three (3) year period following the grant date; provided, that all shares subject to the option will vest and become exercisable upon a "change in control" (as defined in the issuer's omnibus incentive plan).
Documents
Issuer
Goosehead Insurance, Inc.
CIK 0001726978
Entity typeother
Related Parties
1- filerCIK 0001737074
Filing Metadata
- Form type
- 4
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 4:12 PM ET
- Size
- 12.6 KB